patient care technologies

FDA’s Digital Health Committee Discusses Generative AI Impacts on Healthcare

FDA’s Digital Health Committee Discusses Generative AI Impacts on Healthcare

NeelRatan

The FDA's digital health committee is convening to discuss the implications of generative AI in healthcare. The meeting aims to address regulatory challenges and opportunities presented by this technology, emphasizing its potential impact on medical device development and patient outcomes.